Kristi Noem leaves a DHS in turmoil. Border walls may be coming to Big Bend National Park. 10 people have died this year in ...

Rentokil Initial plc (NYSE:RTO) Q4 2025 Earnings Call Transcript March 5, 2026 Operator: Hello, and welcome to the Rentokil Full Year Results 2025. My name is Carla, and I will be coordinating your ...

Good morning, everyone, and welcome to IMI's 2025 Full Year Results Presentation. I am joined here today by our CFO, Luke Grant. Together, we will take you through another year of strong strategic and ...

Keros Therapeutics, Inc. ("Keros" or the "Company") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing ...

In today's call, I will cover the success we are having with our new products, how Okta secures AI, including some early ...

Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...

Q4 2025 Earnings Call March 3, 2026 4:30 PM ESTCompany ParticipantsOliver Gloe - Chief Financial OfficerSean Gadd - President, ...

Held Type A meeting with FDA to discuss AMT-130 for Huntington’s disease; Company evaluating Phase III development considerations and plans to ...

Comprehensive training with proven 9-step blueprint, mentorship, and tools to build a notary signing business.

Our round-up of the best in recent data journalism also highlights medical exam pass rates in Brazil, access to quality water ...

Hyderabad IAP session highlights why retirement planning must start early, stay realistic about costs, and focus on long-term ...

Christina Gentry, DVM, DACVM, discusses dermatologic signs that a patient is in need of immediate attention, including ...